Saper Robert B, Phillips Russell S, Sehgal Anusha, Khouri Nadia, Davis Roger B, Paquin Janet, Thuppil Venkatesh, Kales Stefanos N
Department of Family Medicine, Boston University School of Medicine and Boston Medical Center, Boston, MA 02118-2317, USA.
JAMA. 2008 Aug 27;300(8):915-23. doi: 10.1001/jama.300.8.915.
Lead, mercury, and arsenic have been detected in a substantial proportion of Indian-manufactured traditional Ayurvedic medicines. Metals may be present due to the practice of rasa shastra (combining herbs with metals, minerals, and gems). Whether toxic metals are present in both US- and Indian-manufactured Ayurvedic medicines is unknown.
To determine the prevalence of Ayurvedic medicines available via the Internet containing detectable lead, mercury, or arsenic and to compare the prevalence of toxic metals in US- vs Indian-manufactured medicines and between rasa shastra and non-rasa shastra medicines.
A search using 5 Internet search engines and the search terms Ayurveda and Ayurvedic medicine identified 25 Web sites offering traditional Ayurvedic herbs, formulas, or ingredients commonly used in Ayurveda, indicated for oral use, and available for sale. From 673 identified products, 230 Ayurvedic medicines were randomly selected for purchase in August-October 2005. Country of manufacturer/Web site supplier, rasa shastra status, and claims of Good Manufacturing Practices were recorded. Metal concentrations were measured using x-ray fluorescence spectroscopy.
Prevalence of medicines with detectable toxic metals in the entire sample and stratified by country of manufacture and rasa shastra status.
One hundred ninety-three of the 230 requested medicines were received and analyzed. The prevalence of metal-containing products was 20.7% (95% confidence interval [CI], 15.2%-27.1%). The prevalence of metals in US-manufactured products was 21.7% (95% CI, 14.6%-30.4%) compared with 19.5% (95% CI, 11.3%-30.1%) in Indian products (P = .86). Rasa shastra compared with non-rasa shastra medicines had a greater prevalence of metals (40.6% vs 17.1%; P = .007) and higher median concentrations of lead (11.5 microg/g vs 7.0 microg/g; P = .03) and mercury (20,800 microg/g vs 34.5 microg/g; P = .04). Among the metal-containing products, 95% were sold by US Web sites and 75% claimed Good Manufacturing Practices. All metal-containing products exceeded 1 or more standards for acceptable daily intake of toxic metals.
One-fifth of both US-manufactured and Indian-manufactured Ayurvedic medicines purchased via the Internet contain detectable lead, mercury, or arsenic.
在很大一部分印度制造的传统阿育吠陀药物中检测到了铅、汞和砷。由于采用了“rasa shastra”(将草药与金属、矿物质和宝石混合)的做法,这些金属可能会存在。美国和印度制造的阿育吠陀药物中是否都存在有毒金属尚不清楚。
确定通过互联网可获得的含有可检测到的铅、汞或砷的阿育吠陀药物的流行情况,并比较美国和印度制造的药物以及“rasa shastra”药物和非“rasa shastra”药物中有毒金属的流行情况。
使用5个互联网搜索引擎并搜索“阿育吠陀”和“阿育吠陀药物”,确定了25个提供传统阿育吠陀草药、配方或阿育吠陀中常用成分的网站,这些产品供口服使用且可供销售。从673种已识别的产品中,在2005年8月至10月随机选择了230种阿育吠陀药物进行购买。记录制造商/网站供应商所在国家、“rasa shastra”状态以及良好生产规范声明。使用X射线荧光光谱法测量金属浓度。
整个样本中以及按制造国家和“rasa shastra”状态分层的含有可检测到的有毒金属的药物的流行情况。
收到并分析了230种所订购药物中的193种。含金属产品的流行率为20.7%(95%置信区间[CI],15.2% - 27.1%)。美国制造产品中金属的流行率为21.7%(95%CI,14.6% - 30.4%),而印度产品中为19.5%(95%CI,11.3% - 30.1%)(P = 0.86)。与非“rasa shastra”药物相比,“rasa shastra”药物中金属的流行率更高(40.6%对17.1%;P = 0.007),铅的中位数浓度更高(11.5微克/克对7.0微克/克;P = 0.03),汞的中位数浓度更高(20800微克/克对34.5微克/克;P = 0.04)。在含金属产品中,95%由美国网站销售,75%声称有良好生产规范。所有含金属产品都超过了有毒金属可接受每日摄入量的1项或多项标准。
通过互联网购买的美国制造和印度制造的阿育吠陀药物中,五分之一含有可检测到的铅、汞或砷。